CAMP4 Therapeutics Corporation – NASDAQ:CAMP

Add to watchlist

$1.7

-3.72

-68.69%

Market closed

Open in about 13 hours

+1772.41%

month

+1772.41%

quarter

+2143.80%

year

Market Cap	110.88M
Enterprise value	312.50M

P/E	-3.42
EV/Sales	1.09
EV/EBITDA	-131.52
Price/Sales	0.40
Price/Book	6.18
PEG ratio	-0.06
EPS	-0.95

Revenue	294.67M
EBITDA	-545K
Income	-34.13M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	-11.79%
Oper. margin	-8.46%
Gross margin	38.38%
EBIT margin	-8.46%
EBITDA margin	-0.18%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

CAMP4 Therapeutics Stock Forecast

M Q Y

Last Year

$17.5

Potential upside: 929.41%

Analysts Price target
Financials & Ratios estimates

CAMP4 Therapeutics Corporation (NASDAQ:CAMP): Profit margin
Aug 2021	79.01M	-5.42M	-6.87%
Nov 2021	68.77M	-11.43M	-16.63%
Feb 2022	68.37M	-9.18M	-13.43%
Feb 2023	78.50M	-8.09M	-10.3%

CAMP4 Therapeutics Corporation (NASDAQ:CAMP): Debt to assets
May 2022	374793000	346.20M	92.37%
Aug 2022	371038000	349.21M	94.12%
Nov 2022	388906000	370.21M	95.19%
Feb 2023	380120000	365.81M	96.24%

CAMP4 Therapeutics Corporation (NASDAQ:CAMP): Cash Flow
Aug 2021	10.37M	-3.47M	-2.30M
Nov 2021	-7.13M	-4.66M	-111K
Feb 2022	-7.53M	-2.95M	585K
Feb 2023	-1.09M	-1.80M	264K

CAMP4 Therapeutics alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

CAMP4 Therapeutics
Employees

CAMP4 Therapeutics Corporation (NASDAQ:CAMP): Employee count
Aug 2023	644
Sep 2023	644
Oct 2023	644
Nov 2023	644
Dec 2023	644
Jan 2024	644
Feb 2024	644
Mar 2024	644
Apr 2024	644
May 2024	644
Jun 2024	644
Jul 2024	644

CAMP4 Therapeutics
Hedge Funds Holdings Q1 2023

29.59% -43.17%

of CAMP is owned by hedge funds

43 -48

hedge funds hold CAMP stock

10.69M -15.76M

shares is hold by hedge funds

CAMP hedge funds holdings changes

CAMP4 Therapeutics
Insider Trading

CAMP4 Therapeutics Corporation (NASDAQ:CAMP): Insider trades (number of shares)
Period	Buy	Sel
Jun 2024	0	8640

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	5 Jun 2024	COHENOUR JASON director director	Common Stock	8,640	$0.83	$7,180
Option	5 Mar 2024	COHENOUR JASON director director	Common Stock	7,824	N/A	N/A
Option	5 Mar 2024	COHENOUR JASON director director	Restricted Stock Units (RSUs)	7,824	N/A	N/A
Option	5 Nov 2023	SCOTT RICHARD M. officer: Chief Legal Officer, Secretary officer: Chief Legal Officer, S..	Common Stock	3,167	N/A	N/A
Option	5 Nov 2023	SCOTT RICHARD M. officer: Chief Legal Officer, Secretary officer: Chief Legal Officer, S..	Restricted Stock Units	3,167	N/A	N/A
Option	5 Sep 2023	CARSON BRENNEN officer: Chief Revenue Officer officer: Chief Revenue Officer	Restricted Stock Units	4,167	N/A	N/A
Option	5 Sep 2023	CARSON BRENNEN officer: Chief Revenue Officer officer: Chief Revenue Officer	Common Stock	4,167	N/A	N/A
Option	28 Jul 2023	SCOTT RICHARD M. officer: Chief Legal Officer, Secretary officer: Chief Legal Officer, S..	Common Stock	3,167	N/A	N/A
Option	28 Jul 2023	SCOTT RICHARD M. officer: Chief Legal Officer, Secretary officer: Chief Legal Officer, S..	Restricted Stock Units	3,167	N/A	N/A
Option	24 Jul 2023	VAN BERKEL MONICA officer: Chief People Officer officer: Chief People Officer	Common Stock	5,540	N/A	N/A

CAMP insider trading transactions

Status	Patent	Filling date	Issue date
Application	Application SYSTEMS AND METHODS FOR CRASH DETERMINATION WITH NOISE FILTERING Filling date: 27 May 2022 Issue date: 8 Sep 2022	27 May 2022	8 Sep 2022
Grant	Grant Utility: Systems and methods for failsafe firmware upgrades Filling date: 23 Mar 2020 Issue date: 6 Sep 2022	23 Mar 2020	6 Sep 2022
Application	Application SYSTEMS AND METHODS FOR VEHICLE EVENT DETECTION Filling date: 30 Nov 2021 Issue date: 25 Aug 2022	30 Nov 2021	25 Aug 2022
Application	Application SYSTEMS AND METHODS FOR IMPACT DETECTION WITH NOISE ATTENUATION OF A SENSOR SIGNAL Filling date: 5 Apr 2022 Issue date: 11 Aug 2022	5 Apr 2022	11 Aug 2022
Grant	Grant Utility: Systems and methods crash determination with noise filtering Filling date: 26 Aug 2019 Issue date: 12 Jul 2022	26 Aug 2019	12 Jul 2022
Grant	Grant Utility: Systems and methods for secure communications in vehicle telematics systems Filling date: 13 May 2020 Issue date: 5 Jul 2022	13 May 2020	5 Jul 2022
Application	Application SYSTEMS AND METHODS FOR DYNAMIC TELEMATICS MESSAGING Filling date: 18 Mar 2022 Issue date: 30 Jun 2022	18 Mar 2022	30 Jun 2022
Grant	Grant Utility: Systems and methods for automatic threshold sensing for UVLO circuits in a multi-battery environment Filling date: 20 Jan 2021 Issue date: 17 May 2022	20 Jan 2021	17 May 2022
Application	Application SYSTEMS AND METHODS FOR DYNAMIC DEVICE PROGRAMMING Filling date: 21 Dec 2021 Issue date: 14 Apr 2022	21 Dec 2021	14 Apr 2022
Grant	Grant Utility: Systems and methods for impact detection with noise attenuation of a sensor signal Filling date: 26 May 2020 Issue date: 5 Apr 2022	26 May 2020	5 Apr 2022

CAMP4 Therapeutics
Earnings Call Transcripts

Quarter	Transcript
Q3 2024 9 Jan 2024	Q3 2024 Earnings Call Transcript
Q2 2024 5 Oct 2023	Q2 2024 Earnings Call Transcript
Q1 2024 10 Jul 2023	Q1 2024 Earnings Call Transcript
Q4 2023 27 Apr 2023	Q4 2023 Earnings Call Transcript

CAMP earnings call transcripts

CAMP4 Therapeutics
Executives

Insider	Age	Compensation
Mr. Jeffery R. Gardner (1960) Pres, Chief Executive Officer & Director	65	$1,710,000
Mr. Arym Diamond (1979) Senior Vice President & Chief Revenue Officer	46	$722,330
Mr. Kurtis Joseph Binder (1970) Executive Vice President, Chief Financial Officer & Principal Accounting Officer	55	$672,690
Mr. Anand Rau (1963) Senior Vice President & Chief Technology Officer	62	$477,350

CAMP4 Therapeutics
Latest News

Monday, 2 December 2024
08:00	CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference	globenewswire.com
Thursday, 21 November 2024
16:05	CAMP4 Reports Third Quarter 2024 Financial Results	globenewswire.com
Tuesday, 5 November 2024
15:06	CAMP4 Analyst Highlights Rare Disease Platform Potential	benzinga.com
Thursday, 10 October 2024
19:07	CAMP4 Announces Pricing of Initial Public Offering	globenewswire.com
Tuesday, 1 October 2024
16:30	Camp4 Therapeutics Targets IPO On Early Positive Results	seekingalpha.com
Tuesday, 24 September 2024
14:06	CalAmp Industrial IoT Gateway Named an OEM Off-Highway 2024 Top New Product Award Recipient	globenewswire.com
Thursday, 29 August 2024
09:25	CalAmp Welcomes Thomas Ayers as General Manager of Edge Device Business	globenewswire.com
Thursday, 8 August 2024
11:45	CAMP SNOOPY GETS BIGGER, BETTER, AND SNOOPY-ER IN 2025	globenewswire.com
Wednesday, 7 August 2024
09:00	CAMP SNOOPY GETS BIGGER, BETTER, AND SNOOPY-ER IN 2025	prnewswire.com
Tuesday, 6 August 2024
09:24	CalAmp Launches Inventory Manager for Seamless Device Deployments	globenewswire.com
Thursday, 1 August 2024
06:00	Lynrock Lake Takes CalAmp Private	globenewswire.com
Tuesday, 9 July 2024
09:25	CalAmp Announces Appointment of Paul Washicko as Senior Vice President of Product Management	globenewswire.com
Thursday, 20 June 2024
09:25	CalAmp Announces General Availability of HMU3640LB Industrial Gateway	globenewswire.com
Tuesday, 18 June 2024
09:04	CAMP, The Family Experience Company, and Simon Announce Collaboration to Bring Play-and-Shop Retail Experiences to Families in Philadelphia & Houston	prnewswire.com
Monday, 3 June 2024
16:30	Canadian GoldCamps Enters into Definitive Agreement to Acquire 70% interest in Murphy Lake Property located in the Athabasca Basin, Saskatchewan	globenewswire.com
09:25	CalAmp Reaches Comprehensive Agreement to Significantly Reduce Debt, Go Private, and Strengthen Financial Flexibility to Support Innovation Through a Consensual Financial Restructuring	globenewswire.com
Wednesday, 1 May 2024
16:35	CalAmp Enhances School Bus Solutions Suite with Dispatch Monitor	globenewswire.com
Thursday, 21 March 2024
06:50	Top 3 Tech Stocks That Could Lead To Your Biggest Gains In March - CalAmp (NASDAQ:CAMP), Luna Innovations (NASDAQ:LUNA)	benzinga.com
Tuesday, 27 February 2024
21:22	CalAmp Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	globenewswire.com
07:10	Top 3 Tech Stocks Which Could Rescue Your Portfolio This Month - Digital Turbine (NASDAQ:APPS), CalAmp (NASDAQ:CAMP)	Benzinga
Tuesday, 13 February 2024
08:09	Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter - CalAmp (NASDAQ:CAMP), eGain (NASDAQ:EGAN)	Benzinga
Tuesday, 26 December 2023
16:30	CalAmp Announces Date for Fiscal 2024 Third Quarter Earnings Conference Call	GlobeNewsWire
Tuesday, 10 October 2023
08:41	Top 5 Tech Stocks You'll Regret Missing This Quarter - Cerence (NASDAQ:CRNC), CalAmp (NASDAQ:CAMP)	Benzinga
Thursday, 5 October 2023
19:33	CalAmp (CAMP) Reports Break-Even Earnings for Q2	Zacks Investment Research
Monday, 25 September 2023
16:00	CalAmp Announces Date for Fiscal 2024 Second Quarter Conference Call	GlobeNewsWire
Thursday, 20 July 2023
07:24	Top 5 Tech Stocks You'll Regret Missing This Quarter - National Instruments (NASDAQ:NATI), CalAmp (NASDAQ:CAMP)	Benzinga
Monday, 10 July 2023
19:24	CalAmp Corp. (CAMP) Q1 2024 Earnings Call Transcript	Seeking Alpha
19:15	CalAmp (CAMP) Reports Q1 Loss, Lags Revenue Estimates	Zacks Investment Research
Friday, 7 July 2023
08:35	Top 5 Tech Stocks You'll Regret Missing This Quarter - ChipMOS TECHNOLOGIES (NASDAQ:IMOS), CalAmp (NASDAQ:CAMP)	Benzinga
Monday, 26 June 2023
17:00	CalAmp Announces Date for Fiscal 2024 First Quarter Earnings Conference Call	GlobeNewsWire

Ideas & Opinions

Seeking Alpha 21 Jul 2022

CalAmp: Down, But Not Out

Frequently Asked Questions (FAQ)

What's the price of CAMP4 Therapeutics stock today?

One share of CAMP4 Therapeutics stock can currently be purchased for approximately $1.7.
When is CAMP4 Therapeutics's next earnings date?

Unfortunately, CAMP4 Therapeutics's (CAMP) next earnings date is currently unknown.
Does CAMP4 Therapeutics pay dividends?

No, CAMP4 Therapeutics does not pay dividends.
How much money does CAMP4 Therapeutics make?

CAMP4 Therapeutics has a market capitalization of 110.88M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.3% to 294.95M US dollars.
What is CAMP4 Therapeutics's stock symbol?

CAMP4 Therapeutics Corporation is traded on the NASDAQ under the ticker symbol "CAMP".
What is CAMP4 Therapeutics's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of CAMP4 Therapeutics?

Shares of CAMP4 Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are CAMP4 Therapeutics's key executives?
CAMP4 Therapeutics's management team includes the following people:
- Mr. Jeffery R. Gardner Pres, Chief Executive Officer & Director(age: 65, pay: $1,710,000)
- Mr. Arym Diamond Senior Vice President & Chief Revenue Officer(age: 46, pay: $722,330)
- Mr. Kurtis Joseph Binder Executive Vice President, Chief Financial Officer & Principal Accounting Officer(age: 55, pay: $672,690)
- Mr. Anand Rau Senior Vice President & Chief Technology Officer(age: 62, pay: $477,350)
How many employees does CAMP4 Therapeutics have?

As Jul 2024, CAMP4 Therapeutics employs 644 workers.
When CAMP4 Therapeutics went public?

CAMP4 Therapeutics Corporation is publicly traded company for less than a year since IPO on 11 Oct 2024.
What is CAMP4 Therapeutics's official website?

The official website for CAMP4 Therapeutics is camp4tx.com.
Where are CAMP4 Therapeutics's headquarters?

CAMP4 Therapeutics is headquartered at One Kendall Square Bldg 1400 West, 3rd Floor, Cambridge, MA.
How can i contact CAMP4 Therapeutics?

CAMP4 Therapeutics's mailing address is One Kendall Square Bldg 1400 West, 3rd Floor, Cambridge, MA and company can be reached via phone at +61 76518867.
What is CAMP4 Therapeutics stock forecast & price target?

Based on 2 Wall Street analysts` predicted price targets for CAMP4 Therapeutics in the last 12 months, the avarage price target is $17.5. The average price target represents a 929.41% change from the last price of $1.7.

CAMP4 Therapeutics Corporation

camp4tx.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

+61 76518867

One Kendall Square Bldg 1400 West, 3rd Floor
Cambridge, MA 02139

CIK: 0001736730
ISIN: US13463J1016
CUSIP: 13463J101